Skip to content

Effects of Brain Stimulation (tDCS) Combined with Cognitive Training on Executive Functioning of Children and Adolescents with ADHD

Effects of Transcranial Direct Current Stimulation (tDCS) Combined with a Developed Cognitive Training Module in Children and Adolescents with ADHD: A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098279
Enrollment
90
Registered
2025-12-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F900- Attention-deficit hyperactivity disorder, predominantly inattentive type Health Condition 2: F901- Attention-deficit hyperactivity disorder, predominantly hyperactive type Health Condition 3: F902- Attention-deficit hyperactivity disorder, combined type Health Condition 4: F908- Attention-deficit hyperactivity disorder, other type Health Condition 5: F909- Attention-deficit hyperactivity disorder, unspecified type

Interventions

Intervention1: Transcranial Direct Current Stimulation: tDCS will be delivered using a Starstim 32 (Neuroelectrics, GmBH) machine, with anode over left dorsolateral prefrontal cortex (dlPFC) and catho

Sponsors

All India Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinical diagnosis of ADHD as per DSM-5 IQ greater than or equal to 80 Availability of at least one parent as an informant Ability to comprehend instructions and cooperate for intervention Ability to read and understand English and/or Hindi

Exclusion criteria

Exclusion criteria: Metal implants or skin lesions near electrode site History of epilepsy, seizures, or other known organic neurological disorders Patients with autism, psychosis or bipolar disorder Uncooperative patient/ parent Has not been a part of any interventional trial in previous 3 months Drug-naive or drug-free for at least 48 hours

Design outcomes

Primary

MeasureTime frame
Changes in Working Memory, Response Inhibition and AttentionTimepoint: Pre and Post Assessment (after 5 sessions)

Secondary

MeasureTime frame
Changes in the spectral values and Oxygenated and Deoxygenated Haemoglobin Concentrations in the dlPFC. Timepoint: Pre and Post Assessment (after 5 sessions)

Countries

India

Contacts

Public ContactAnanya Gupta

All India Institute of Medical Sciences (AlIMS), New Delhi

patrabaiims@gmail.com9717880196

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026